Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2308) 2308
Book Review (500) 500
Publication (112) 112
Book / eBook (30) 30
Book Chapter (17) 17
Conference Proceeding (14) 14
Magazine Article (6) 6
Newspaper Article (5) 5
Paper (2) 2
Dissertation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1617) 1617
index medicus (1549) 1549
hereditary angioedema (1374) 1374
female (841) 841
immunology (679) 679
male (671) 671
allergy (605) 605
adult (600) 600
angioedema (507) 507
angioneurotic edema (488) 488
middle aged (462) 462
bradykinin (384) 384
c1 inhibitor (379) 379
angioedemas, hereditary - drug therapy (362) 362
management (352) 352
adolescent (316) 316
edema (313) 313
c1 inhibitor deficiency (276) 276
angioedemas, hereditary - diagnosis (262) 262
aged (261) 261
child (258) 258
diagnosis (251) 251
abridged index medicus (241) 241
deficiency (224) 224
young adult (221) 221
complement c1 inhibitor protein - therapeutic use (220) 220
mutation (216) 216
treatment outcome (209) 209
complement c1 inhibitor protein (208) 208
c1-inhibitor (203) 203
medicine, general & internal (202) 202
allergy and immunology (195) 195
angioedema - genetics (189) 189
therapy (186) 186
angioedema - diagnosis (175) 175
angioneurotic-edema (174) 174
complement (173) 173
plasma (167) 167
animals (164) 164
c1-inhibitor deficiency (160) 160
attacks (159) 159
icatibant (158) 158
c1 esterase inhibitor (152) 152
bradykinin - analogs & derivatives (149) 149
angioedemas, hereditary - genetics (144) 144
patients (137) 137
care and treatment (135) 135
complement c1 inactivator proteins - genetics (135) 135
diagnosis, differential (135) 135
angioedema - drug therapy (134) 134
danazol (132) 132
dermatology (130) 130
angioedema - etiology (127) 127
bradykinin - therapeutic use (124) 124
complement c1 inactivator proteins - deficiency (122) 122
prophylaxis (122) 122
angioedema - therapy (120) 120
drug therapy (120) 120
genetic aspects (120) 120
child, preschool (119) 119
concentrate (119) 119
complement c1 inhibitor protein - genetics (114) 114
internal medicine (114) 114
kallikrein (113) 113
angioedemas, hereditary - therapy (112) 112
analysis (111) 111
pregnancy (110) 110
risk factors (109) 109
angioedemas, hereditary - complications (108) 108
complement c1 inhibitor protein - metabolism (106) 106
hereditary angioneurotic-edema (106) 106
retrospective studies (106) 106
disease (103) 103
acute attacks (101) 101
research (101) 101
acquired angioedema (99) 99
pharmacology & pharmacy (99) 99
complement c1 inhibitor protein - administration & dosage (98) 98
activation (96) 96
complement c1 inactivator proteins - therapeutic use (96) 96
hereditary (96) 96
inhibitor (96) 96
quality of life (96) 96
symptoms (96) 96
urticaria (94) 94
acute disease (92) 92
pediatrics (92) 92
genetic disorders (91) 91
medicine & public health (91) 91
c1 inhibitor concentrate (90) 90
angioedemas, hereditary - physiopathology (89) 89
health aspects (89) 89
enzymes (88) 88
c1-esterase inhibitor (86) 86
esterase inhibitor (86) 86
molecular-weight kininogen (84) 84
medicine (82) 82
bradykinin - metabolism (81) 81
ecallantide (81) 81
gene (80) 80
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (25) 25
UTL at Downsview - May be requested (4) 4
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Dentistry (Harry R Abbott) - Withdrawn (1) 1
Gerstein Science - Reference (1) 1
Holland Bloorview Kids Rehabilitation - Stacks (1) 1
Lakeridge Health Sciences - Oshawa (1) 1
Scarborough Hospital - Birchmount (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Michael's Hospital - Stacks (1) 1
Trillium Health Centre - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
UofT at Scarborough - Sunnybrook Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2061) 2061
French (81) 81
German (79) 79
Spanish (56) 56
Japanese (30) 30
Portuguese (12) 12
Polish (10) 10
Turkish (10) 10
Italian (8) 8
Czech (6) 6
Korean (6) 6
Croatian (4) 4
Danish (4) 4
Hungarian (4) 4
Chinese (2) 2
Slovak (2) 2
Bosnian (1) 1
Dutch (1) 1
Finnish (1) 1
Hebrew (1) 1
Romanian (1) 1
Serbian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Angioedema
by Zuraw, Bruce L and Alam, Rafeul
2006, Immunology and allergy clinics of North America, ISBN 9781416038092, Volume 26, no. 4., xv, 387-601
Angioneurotic edema
Book
Details down arrow
2. Angioedema
by Aberer, W
ALLERGOLOGIE, ISSN 0344-5062, 03/2013, Volume 36, Issue 3, pp. 83 - 84
HEREDITARY ANGIOEDEMA | ALLERGY | THERAPIES | OPTIONS | URTICARIA
Journal Article
Details down arrow
3. Full Text A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor–associated angioedema
by Zuraw, Bruce L., MD and Bernstein, Jonathan A., MD and Lang, David M., MD and Craig, Timothy, DO and Dreyfus, David, MD and Hsieh, Fred, MD and Khan, David, MD and Sheikh, Javed, MD and Weldon, David, MD and Bernstein, David I., MD and Blessing-Moore, Joann, MD and Cox, Linda, MD and Nicklas, Richard A., MD and Oppenheimer, John, MD and Portnoy, Jay M., MD and Randolph, Christopher R., MD and Schuller, Diane E., MD and Spector, Sheldon L., MD and Tilles, Stephen A., MD and Wallace, Dana, MD and American College of Allergy, Asthma and Immunology and American Academy of Allergy, Asthma and Immunology
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2013, Volume 131, Issue 6, pp. 1491 - 1493.e25
These parameters were developed by the Joint Task Force on Practice Parameters (JTFPP), representing the American Academy of Allergy, Asthma & Immunology... 
Allergy and Immunology | angioedema | hereditary angioedema | acquired C1 inhibitor deficiency | bradykinin | Angiotensin-converting enzyme inhibitor | angiotensin receptor blocker | C1 inhibitor deficiency | RECEPTOR ANTAGONIST ICATIBANT | MOLECULAR-WEIGHT KININOGEN | HUMAN C1-INHIBITOR CONCENTRATE | IMMUNOLOGY | HUMAN C1BAR INHIBITOR | ANGIONEUROTIC-EDEMA | DANAZOL PROPHYLAXIS | 1ST COMPLEMENT COMPONENT | ALLERGY | FRESH-FROZEN PLASMA | LONG-TERM SURVEY | ESTERASE INHIBITOR | Hereditary Angioedema Types I and II - etiology | Angioedema - therapy | Angiotensin-Converting Enzyme Inhibitors - metabolism | Humans | Angioedema - diagnosis | Angioedema - etiology | Hereditary Angioedema Types I and II - therapy | Hereditary Angioedema Types I and II - diagnosis | Angioneurotic edema | Task forces | Enzyme inhibitors | Angiotensin | Enzymes | Plasma | Larynx | Laboratories | Drug dosages | Mortality | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Hereditary angioedema (HAE) in children and adolescents—a consensus on therapeutic strategies
by Wahn, V and Aberer, W and Eberl, W and Faßhauer, M and Kühne, T and Kurnik, K and Magerl, M and Meyer-Olson, D and Martinez-Saguer, I and Späth, P and Staubach-Renz, P and Kreuz, W
European Journal of Pediatrics, ISSN 0340-6199, 9/2012, Volume 171, Issue 9, pp. 1339 - 1348
Hereditary angioedema due to C1 inhibitor (C1 esterase inhibitor) deficiency (types I and II HAE-C1-INH) is a rare disease that usually presents during... 
Pediatrics | C1-INH (C1 inhibitor, C1-esterase inhibitor) | Hereditary angioedema | Medicine & Public Health | Pediatric | Consensus | ACUTE ATTACKS | MANAGEMENT | HUMAN C1-INHIBITOR | C1 INHIBITOR CONCENTRATE | ECALLANTIDE | DEFICIENCY | LONG-TERM PROPHYLAXIS | ANGIONEUROTIC EDEMA | ACID THERAPY | DOUBLE-BLIND | PEDIATRICS | Bradykinin - analogs & derivatives | Complement C1 Inactivator Proteins - therapeutic use | Recombinant Proteins - therapeutic use | Antifibrinolytic Agents - therapeutic use | Complement C1 Inhibitor Protein - therapeutic use | Bradykinin - therapeutic use | Humans | Switzerland | Disease Progression | Austria | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Adolescent | Complement Inactivating Agents - therapeutic use | Hereditary Angioedema Types I and II - drug therapy | Adult | Androgens - therapeutic use | Child | Germany | Peptides - therapeutic use | Medical colleges | Angioneurotic edema | Children | Health aspects | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Comparing acquired angioedema with hereditary angioedema (Types I/II): Findings from the icatibant outcome survey
by Longhurst, Hilary J and Zanichelli, A and Caballero, T and Bouillet, L and Aberer, W and Maurer, M and Fain, O and Fabien, V and Andresen, I and IOS Study Grp and IOS Study Group
Clinical and Experimental Immunology, ISSN 0009-9104, 04/2017, Volume 188, Issue 1, pp. 148 - 153
Icatibant is used to treat acute hereditary angioedema with C1 inhibitor deficiency types I/II (C1-INH-HAE types I/II) and has shown promise in angioedema due... 
Acquired angioedema | Icatibant | Hereditary angioedema | hereditary angioedema | DIAGNOSIS | ATTACKS | INHIBITOR DEFICIENCY | acquired angioedema | C1-INHIBITOR DEFICIENCY | icatibant | IMMUNOLOGY | INTERNATIONAL WORKING GROUP | CONSENSUS REPORT | Bradykinin - analogs & derivatives | Severity of Illness Index | Angioedema - epidemiology | Bradykinin - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Male | Treatment Outcome | Angioedemas, Hereditary - epidemiology | Disease Progression | Angioedema - drug therapy | Phenotype | Aged, 80 and over | Angioedemas, Hereditary - diagnosis | Adult | Angioedema - diagnosis | Female | Surveys and Questionnaires | Aged | Retrospective Studies | Angioedemas, Hereditary - drug therapy | Bradykinin - administration & dosage | Surveys | Angioneurotic edema | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text C1 esterase inhibitor concentrate in 1085 Hereditary Angioedema attacks – final results of the I.M.P.A.C.T.2 study
by Craig, T. J and Bewtra, A. K and Bahna, S. L and Hurewitz, D and Schneider, L. C and Levy, R. J and Moy, J. N and Offenberger, J and Jacobson, K. W and Yang, W. H and Eidelman, F and Janss, G and Packer, F. R and Rojavin, M. A and Machnig, T and Keinecke, H.‐O and Wasserman, R. L
Allergy, ISSN 0105-4538, 12/2011, Volume 66, Issue 12, pp. 1604 - 1611
Background: The placebo-controlled study International Multicentre Prospective Angioedema C1-INH Trial 1 (I.M.P.A.C.T.1) demonstrated that 20 U/kg C1 esterase... 
C1‐inhibitor replacement therapy | C1 esterase inhibitor concentrate | Berinert | Hereditary Angioedema | C1-inhibitor replacement therapy | AUTOANTIBODIES | C1-INHIBITOR CONCENTRATE | ALLERGY | IMMUNOLOGY | RELIEF | Complement C1 Inhibitor Protein - therapeutic use | Humans | Middle Aged | Male | Treatment Outcome | Complement C1 Inhibitor Protein - adverse effects | Young Adult | Adolescent | Antibodies - immunology | Adult | Female | Angioedemas, Hereditary - drug therapy | Complement C1 Inhibitor Protein - administration & dosage | Child | Viral antibodies | Angioneurotic edema | Analysis | Antibodies | Hormones, Sex | Genetic aspects | Universities and colleges | Consulting services | Drug therapy | Genetic disorders | Immune system | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Cost-utility analysis of Ruconest® (conestat alfa) compared to Berinert® P (human C1 esterase inhibitor) in the treatment of acute, life-threatening angioedema attacks in patients with hereditary angioedema
by Kawalec, Paweł and Holko, Przemysław and Paszulewicz, Anna
Postepy Dermatologii i Alergologii, ISSN 1642-395X, 2013, Volume 30, Issue 3, pp. 152 - 158
Introduction: Administration of human Cl esterase inhibitor (Berinert (R) P) from target import is the most widespread treatment strategy for patients with... 
Human C1 esterase inhibitor | Conestat alfa | Hereditary angioedema | Cost-utility analysis | Acute angioedema attacks | TRIALS | MANAGEMENT | cost-utility analysis | human C1 esterase inhibitor | POLAND | DEFICIENCY | DERMATOLOGY | hereditary angioedema | CONCENTRATE | THERAPY | ALLERGY | conestat alfa | QUALITY-OF-LIFE | acute angioedema attacks | Original Paper
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Angioedema - An interdisciplinary emergency
by Hahn, Janina and Hoffmann, Thomas K and Bock, Bastian and Nordmann-Kleiner, Melanie and Trainotti, Susanne and Greve, Jens
Deutsches Arzteblatt International, ISSN 1866-0452, 07/2017, Volume 114, Issue 29-30, pp. 489 - 496
Background: Acute angioedema of the upper airways can be life-threatening. An important distinction is drawn between mast-cell-mediated angioedema and... 
INDIVIDUALS | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | HEREDITARY ANGIOEDEMA | EDEMA | INHIBITOR-INDUCED ANGIOEDEMA | MEDIATED ANGIOEDEMA | HISTAMINE H-1 RECEPTOR | ANAPHYLAXIS | BRADYKININ | EPIDEMIOLOGY | Review
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Hereditary angioedema
by Frank, MM
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, ISSN 0091-6749, 02/2008, Volume 121, Issue 2, pp. S398 - S401
Hereditary angioedema is an episodic swelling disorder with autosomal dominant inheritance. Attacks are characterized by brawny, self-limited, nonpruritic... 
MANAGEMENT | androgens | bradykinin | C1 inhibitor | C1-INHIBITOR | IMMUNOLOGY | C1 esterase inhibitor | hereditary angioedema | CONCENTRATE | INHIBITOR DEFICIENCY | ANGIONEUROTIC EDEMA | THERAPY | ALLERGY | antifibrinolytics | danazol | complement
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Recurrent Angioedema
by Ledford, Dennis K and Craig, Timothy J
The Journal of Allergy and Clinical Immunology: In Practice, ISSN 2213-2198, 07/2018, Volume 6, Issue 4, pp. 1427 - 1429
In addition to mutations in Factor XII of the clotting cascade (Hageman factor), there are reports of plasminogen abnormalities being associated with AE.2 Of... 
IDIOPATHIC NONHISTAMINERGIC ANGIOEDEMA | ICATIBANT | IMMUNOLOGY | HEREDITARY ANGIOEDEMA | ALLERGY | Laboratories | Angioedema | Gastrointestinal surgery | Family medical history | Mutation | Patients | Abdomen
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Angioedema
by Frigas, E and Nzeako, UC
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, ISSN 1080-0549, 10/2002, Volume 23, Issue 2, pp. 217 - 231
Angioedema is a constellation of syndromes that present a great challenge to the clinician. The term "angioedema" describes the localized, transient, episodic... 
ACTIVATION | gastrointestinal tract | HEREDITARY ANGIONEUROTIC-EDEMA | skin | ACQUIRED C1-INHIBITOR DEFICIENCY | SYMPTOMS | CONVERTING ENZYME-INHIBITORS | IMMUNOLOGY | C1 INHIBITOR | abdominal pain | THERAPY | PLASMA | ALLERGY | urticaria | DANAZOL | angiodema | BRADYKININ
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema
by Zuraw, Bruce, MD and Cicardi, Marco, MD and Levy, Robyn J., MD and Nuijens, Jan H., MD, PhD and Relan, Anurag, MD and Visscher, Sonja and Haase, Gerald, MD and Kaufman, Leonard, PhD and Hack, C. Erik, MD, PhD
Journal of Allergy and Clinical Immunology, The, ISSN 0091-6749, 2010, Volume 126, Issue 4, pp. 821 - 827.e14
Background Hereditary angioedema (HAE) results from a genetic deficiency of C1-inhibitor. Two similar independent, randomized, saline controlled, double-blind... 
Allergy and Immunology | angioedema | recombinant human C1-inhibitor | HAE | attack | safety | efficacy | MANAGEMENT | ABDOMINAL-PAIN | ALLERGY | C1 INHIBITOR CONCENTRATE | IMMUNOLOGY | LARYNGEAL EDEMA | Recombinant Proteins - therapeutic use | Complement C1 Inhibitor Protein - therapeutic use | Acute Disease | Injections, Intravenous | Double-Blind Method | Europe | Humans | Complement C1 Inhibitor Protein - immunology | Male | Treatment Outcome | Recombinant Proteins - adverse effects | North America | Recombinant Proteins - administration & dosage | Complement C1 Inhibitor Protein - adverse effects | Angioedemas, Hereditary - immunology | Recombinant Proteins - immunology | Female | Angioedemas, Hereditary - drug therapy | Complement C1 Inhibitor Protein - administration & dosage | Pain Measurement | Complications and side effects | Angioneurotic edema | Drug therapy | Consulting services | Proteins | Studies | Plasma | Pain | Larynx | Reproductive system | Abdomen | Milk | Index Medicus | Abridged Index Medicus | Antibodies
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Inhibiting Plasma Kallikrein for Hereditary Angioedema Prophylaxis
by Banerji, Aleena and Busse, Paula and Shennak, Mustafa and Lumry, William and Davis-Lorton, Mark and Wedner, Henry J and Jacobs, Joshua and Baker, James and Bernstein, Jonathan A and Lockey, Richard and Li, H. Henry and Craig, Timothy and Cicardi, Marco and Riedl, Marc and Al-Ghazawi, Ahmad and Soo, Carolyn and Iarrobino, Ryan and Sexton, Daniel J and TenHoor, Christopher and Kenniston, Jon A and Faucette, Ryan and Still, J. Gordon and Kushner, Harvey and Mensah, Robert and Stevens, Chris and Biedenkapp, Joseph C and Chyung, Yung and Adelman, Burt
The New England Journal of Medicine, ISSN 0028-4793, 02/2017, Volume 376, Issue 8, pp. 717 - 728
In patients with hereditary angioedema with C1 inhibitor deficiency, swelling episodes are related to the release of bradykinin from high-molecular-weight... 
ATTACKS | MEDICINE, GENERAL & INTERNAL | MANAGEMENT | RECOMMENDATIONS | DANAZOL | BURDEN | DEFICIENCY | INTERNATIONAL WORKING GROUP | BRADYKININ-FORMING CASCADE | CONSENSUS REPORT | Double-Blind Method | Antibodies, Monoclonal - pharmacology | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Plasma Kallikrein - antagonists & inhibitors | Male | Treatment Outcome | Angioedemas, Hereditary - prevention & control | Antibodies, Monoclonal - blood | Dose-Response Relationship, Drug | Young Adult | Antibodies, Monoclonal - administration & dosage | Adult | Female | Monoclonal antibodies | Angioneurotic edema | Care and treatment | Usage | Diagnosis | Fees & charges | Headache | Plasma | Antigens | Angioedema | Prophylaxis | Kallikrein | Family medical history | Patients | Manuscripts | Complement component C1 | Androgens | Pain | Inventors | Bradykinin | Plasma kallikrein | Larynx | Plasma levels | Kininogens | Drug dosages | Pharmaceuticals | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Sitagliptin and angioedema
by Arcani, Robin and Martinez, Sonia and Gayet, Stéphane
Annals of Internal Medicine, ISSN 0003-4819, 07/2017, Volume 167, Issue 2, pp. 142 - 143
HEREDITARY ANGIOEDEMA | PEPTIDASE-IV INHIBITOR | MEDICINE, GENERAL & INTERNAL | Humans | Middle Aged | Angioedema - chemically induced | Male | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Sitagliptin Phosphate - adverse effects | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text WAO guideline for the management of hereditary angioedema
by Craig, Timothy and Pürsün, Emel Aygören and Bork, Konrad and Bowen, Tom and Boysen, Henrik and Farkas, Henriette and Grumach, Anete and Katelaris, Constance H and Lockey, Richard and Longhurst, Hilary and Lumry, William and Magerl, Markus and Martinez-Saguer, Immaculada and Ritchie, Bruce and Nast, Alexander and Pawankar, Ruby and Zuraw, Bruce and Maurer, Marcus
World Allergy Organization Journal, ISSN 1939-4551, 2012, Volume 5, Issue 12, pp. 182 - 199
: Hereditary Angioedema (HAE) is a rare disease and for this reason proper diagnosis and appropriate therapy are often unknown or not available for physicians... 
Therapy | Hereditary Angioedema | Medications | Diagnosis | Management | HAE | Guidelines | International | Angioneurotic edema | Care and treatment | Health care industry | Evidence-based medicine
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text The Angioedema Quality of Life Questionnaire (AE‐QoL) – assessment of sensitivity to change and minimal clinically important difference
by Weller, K and Magerl, M and Peveling‐Oberhag, A and Martus, P and Staubach, P and Maurer, M
Allergy, ISSN 0105-4538, 08/2016, Volume 71, Issue 8, pp. 1203 - 1209
BackgroundThe Angioedema Quality of Life Questionnaire (AE-QoL) has recently been developed and validated as the first specific patient-reported outcome tool... 
angioedema | quality of life | minimal clinically important difference | responsivity | sensitivity to change | DIAGNOSIS | HEREDITARY ANGIOEDEMA | VALIDATION | CLASSIFICATION | IMMUNOLOGY | DISEASE-ACTIVITY | IMPAIRMENT | ALLERGY | CHRONIC SPONTANEOUS URTICARIA | Recurrence | Reproducibility of Results | Urticaria - epidemiology | Angioedema - epidemiology | Humans | Middle Aged | Male | Quality of Life | Adult | Female | Surveys and Questionnaires | Minimal Clinically Important Difference | Chronic Disease | Surveys | Angioneurotic edema | Analysis | Allergies | Questionnaires | Quality of life | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Canadian hereditary angioedema guideline
by Betschel, S and Badiou, J and Binkley, K and Hebert, J and Kanani, A and Keith, P and Lacuesta, G and Yang, B and Aygoren-Pursun, E and Bernstein, J and Bork, K and Caballero, T and Cicardi, M and Craig, T and Farkas, H and Longhurst, H and Zuraw, B and Boysen, H and Borici-Mazi, R and Bowen, T and Dallas, K and Dean, J and Lang-Robertson, K and Laramee, B and Leith, E and Mace, S and McCusker, C and Moote, B and Poon, MC and Ritchie, B and Stark, D and Sussman, G and Waserman, S
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, ISSN 1710-1484, 10/2014, Volume 10, Issue 1, pp. 50 - 50
Hereditary angioedema (HAE) is a disease which is associated with random and often unpredictable attacks of painful swelling typically affecting the... 
UNITED-STATES | Self-administration | Comprehensive care | C1-INHIBITOR CONCENTRATE | Individualized therapy | Acute attacks | Guideline | IMMUNOLOGY | Long-term prophylaxis | Quality of life | INTERNATIONAL WORKING GROUP | ATTENUATED ANDROGENS | Recommendations | C1 INHIBITOR DEFICIENCY | ECALLANTIDE TREATMENT | Hereditary angioedema | ALLERGY | Short-term prophylaxis | REPLACEMENT THERAPY | GRADE | QUALITY-OF-LIFE | LONG-TERM SURVEY | Health care industry | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights